#antiretrovirals

The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.

Quitting, even at age 40, can drastically lower this risk.

Getting 70 percent of the HIV population virally suppressed by 2020 would prevent a vast number of deaths over two decades.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.

Jesús Aguais is the founder and executive director of Aid for AIDS.

A recent study tested the long-acting injectable antiretrovirals cabotegravir and Edurant (rilpivirine) given every four or eight weeks.

Scientists are investigating how the apparent size of an individual’s reservoir may help predict the length of viral remission.

Writer Anna Forbes responds to an open letter by HIV researcher David Alain Wohl, MD, that urges AIDS activists to do more.